Innospec (IOSP) Market Cap

Price: $97.36
Market Cap: $2.43B
Avg Volume: 204.59K
Country: US
Industry: Chemicals - Specialty
Sector: Basic Materials
Beta: 1.064
52W Range: $95.17-133.71
Website: Innospec

Market Cap Overview

Market Cap

$2.43B

Share Price

$97.36

Shares Outstanding

24.96M


What is Innospec's Market Cap?

Innospec's current Market Cap as of today is $2.43B.

Understanding Market Capitalization

Market Capitalization (Market Cap) is the total value of a company's outstanding shares of stock. It is calculated by multiplying the current market price of one share by the total number of outstanding shares.

  • It provides a straightforward method of gauging a company's size.
  • Market Cap can be used to compare companies within the same industry.

How is Market Cap calculated?

Market Cap is calculated by multiplying the current share price by the total number of outstanding shares:

Market Cap = Current Share Price × Total Shares Outstanding

In the case of Innospec, the market cap is calculated as $97.36 x 24.96M shares = $2.43B.

As a Mid Cap company, Innospec is a medium-sized company with significant growth potential.

Innospec Historical Market Cap

$3.50B$3.50B$3.00B$3.00B$2.50B$2.50B$2.00B$2.00B$1.50B$1.50B$1.00B$1.00BMarket CapJul '20Jul '2020212021Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '2320242024Jul '24Jul '2420252025
Download SVG
Download PNG
Download CSV

Innospec Market Cap vs Enterprise Value

Understanding Market Cap vs. Enterprise Value

While market cap represents the equity value of Innospec, enterprise value provides a more complete picture of the company's total value by including debt and cash:

Market Cap
Enterprise Value
$3.20B$3.20B$2.40B$2.40B$1.60B$1.60B$800.00M$800.00M$0.00$0.00ValueJul '20Jul '2020212021Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '2320242024Jul '24Jul '2420252025
Download SVG
Download PNG
Download CSV

Enterprise Value = Market Cap + Total Debt - Cash and Equivalents

Innospec's enterprise value as of December 31, 2024 (Q4 2024) is calculated as:

  • Market Cap: $2.43B
  • Total Debt: $44.90M
  • Cash and Equivalents: $289.20M
  • Enterprise Value: $2.50B

The difference between market cap and enterprise value can indicate the company's financial leverage and cash position. A higher enterprise value suggests significant debt levels.

Innospec Annual Market Cap History

Year Market Cap Change
2025 $2.43B -11.44%
2024 $2.74B -10.40%
2023 $3.06B 20.12%
2022 $2.55B 14.51%
2021 $2.23B -0.09%
2020 $2.23B -12.00%
2019 $2.53B 68.04%
2018 $1.51B -11.60%
2017 $1.70B 3.71%
2016 $1.64B 25.56%
2015 $1.31B 25.71%
2014 $1.04B -4.73%
2013 $1.09B 36.69%
2012 $799.72M 16.19%
2011 $688.28M 42.02%
2010 $484.62M 103.16%
2009 $238.55M 71.65%
2008 $138.97M -66.14%
2007 $410.47M -26.97%
2006 $562.03M 179.13%
2005 $201.35M -21.66%
2004 $257.02M 9.31%
2003 $235.13M 25.97%
2002 $186.66M -11.85%
2001 $211.75M 46.36%
2000 $144.68M 0.81%
1999 $143.52M -28.76%
1998 $201.45M N/A

Frequently Asked Questions

Innospec's current market capitalization is $2.43B. This makes it a Mid Cap company, calculated by multiplying its current stock price of $97.36 by 24.96M outstanding shares.

Innospec's enterprise value is $2.50B. This is calculated by adding total debt ($44.90M) to market cap and subtracting cash and equivalents ($289.20M). Enterprise value provides a more complete picture of the company's total value by considering both its debt and cash positions.

Innospec has 24.96M shares outstanding. This number represents the total number of shares currently held by all shareholders, including company insiders, institutional investors, and the public.

Innospec is classified as a Mid Cap company. Mid-cap companies are established companies with market caps between $2 billion and $10 billion.

Innospec's market cap is calculated by multiplying its current stock price ($97.36) by its total number of outstanding shares (24.96M). This calculation represents the total market value of all the company's outstanding shares at the current market price.

Related Metrics

Explore detailed financial metrics and analysis for IOSP.